Article Information
History
- October 17, 2021.
Article Versions
- Version 1 (September 24, 2021 - 21:13).
- Version 2 (September 25, 2021 - 01:01).
- You are currently viewing Version 3 of this article (October 17, 2021 - 16:49).
- Version 4 (December 22, 2021 - 07:20).
- Version 5 (May 12, 2022 - 07:31).
- View Version 6, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yuan Tian1,#,
- Rui Xing2,#,
- Jing Zhou1,#,
- Juanli Qiao1,
- Zhaojun Liu1,
- Liankun Gu1,
- Baozhen Zhang1,
- Jiafu Ji3,
- Youyong Lu2 and
- Dajun Deng1,*
- 1Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Beijing, 100142, China
- 2Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Tumor Biology, Peking University Cancer Hospital and Institute, Beijing, 100142, China
- 3Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Surgical Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, China
- ↵*Corresponding author:
Dajun Deng, Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Fu-Cheng-Lu #52, Haidian District, Beijing, 100142, China, Phone:+8610-88196752 (E-mail: dengdajun{at}bjmu.edu.cn)
↵# Equal first authors